Crédit Industriel et Commercial’s Amicus Therapeutics FOLD Stock Holding History

Crédit Industriel et Commercial’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-771,948	Closed	-$11.2M	–	368
2026 Q1	$11.2M	Buy	771,948 +531,948	+222%	+$7.63M	0.87%	23
2025 Q4	$3.42M	Buy	+240,000	New	+$2.36M	0.26%	94

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Crédit Industriel et Commercial's FOLD Position: Q2 2026 in Review

Crédit Industriel et Commercial sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 771,948 shares — an estimated $11.2M sold.

Crédit Industriel et Commercial first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $11.2M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Crédit Industriel et Commercial reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Crédit Industriel et Commercial sold 771,948 Amicus Therapeutics shares in Q2 2026, an estimated $11.2M.
Crédit Industriel et Commercial first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Crédit Industriel et Commercial's Amicus Therapeutics position peaked at $11.2M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q2 2026, filed 24 Jul 2026.